Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Sherva, Richard ^a   Sripichai, Orapan ^c,d   Abel, Kenneth ^e,f   Ma, Qianli ^a   Whitacre, Johanna ^e,g   Angkachatchai, Vach ^e   Makarasara, Wattanan ^c   Winichagoon, Pranee ^c   Svasti, Saovaros ^c   Fucharoen, Suthat ^c   Braun, Andreas ^e,h   Farrer, Lindsay A ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Sequenom Inc ^*  (Thailand)

^e SEQUENOM INC   (United States)

^f HUMAN BIOMOLECULAR RESEARCH INSTITUTE   (United States)

^g ILLUMINA INC   (United States)

^h Dx Innovations Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN E;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROPOIESIS; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND; GENETICS; HOSPITALIZATION;

BETA-GLOBINS; BETA-THALASSEMIA; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEMOGLOBIN E; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 77950445745     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-51     Document Type: Article

References (30)

1. Higgs DR, Thein SL, Woods WG, . ed The molecular pathology of the thalassaemias. The Thalassaemia Syndromes 2001, 133-191. Oxford, England: Blackwell Science, ed.
2. Traeger J, Wood WG, Clegg JB, Weatherall DJ. Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature 1980, 288:497-499. 10.1038/288497a0, 7442796.
3. Orkin SH, Kazazian HH, Antonarakis SE, Ostrer H, Goff SC, Sexton JP. Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature 1982, 300:768-769. 10.1038/300768a0, 7177196.
4. Fucharoen S, Winichagoon P, Pootrakul P, Piankijagum A, Wasi P. Variable severity of Southeast Asian beta 0-thalassemia/Hb E disease. Birth Defects Orig Artic Ser 1987, 23:241-248.
5. Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P. Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol 2000, 22:552-557. 10.1097/00043426-200011000-00022, 11132229.
6. Fucharoen S, Winichagoon P. Clinical and hematologic aspects of hemoglobin E beta-thalassemia. Curr Opin Hematol 2000, 7:106-112. 10.1097/00062752-200003000-00006, 10698297.
7. Beutler E, Lichtman M, Coller BS, Kipps TJ, Seligsohn U, . ed The sickle cell diseases and related disorders. Williams Hematology 2001, 581-605. New York: McGraw Hill, ed.
8. Weatherall DJ, Pressley L, Wood WG, Higgs DR, Clegg JB. Molecular basis for mild forms of homozygous beta-thalassaemia. Lancet 1981, 1:527-529. 10.1016/S0140-6736(81)92864-6, 6111635.
9. Nuntakarn L, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A, Wiangnon S. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand. Blood Cells Mol Dis 2009, 42:32-35. 10.1016/j.bcmd.2008.09.002, 18951049.
10. Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. NatGenet 2007, 39:1197-1199.
11. Garner C, Tatu T, Reittie JE, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000, 342-346.
12. Gibney GT, Panhuysen CI, So JC, et al. Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong. Am J Hematol 2008, 83:458-464. 10.1002/ajh.21150, 18266208.
13. Pandit RA, Svasti S, Sripichai O, et al. Association of SNP in exon 1 of HBS1L with hemoglobin F level in beta0-thalassemia/hemoglobin E. Int J Hematol 2008, 88:357-361. 10.1007/s12185-008-0167-3, 18839276.
14. Chen Z, Luo HY, Steinberg MH, Chui DH. BCL11A represses HBG transcription in K562 cells. Blood Cells Mol Dis 2009, 42:144-149. 10.1016/j.bcmd.2008.12.003, 19153051.
15. Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis 2008, 41:255-258. 10.1016/j.bcmd.2008.06.007, 18691915.
16. Berrahmoune H, Herbeth B, Lamont JV, Fitzgerald PS, Visvikis-Siest S. Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration. Atherosclerosis 2007, 192:348-353. 10.1016/j.atherosclerosis.2006.05.015, 16814297.
17. Yang Q, Kathiresan S, Lin JP, Tofler GH, O'Donnell CJ. Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet 2007, 8(Suppl 1):S12. 10.1186/1471-2350-8-S1-S12, 1995619, 17903294.
18. Sripichai O, Whitacre J, Munkongdee T, et al. Genetic analysis of candidate modifier polymorphisms in Hb E-beta 0-thalassemia patients. Ann N Y Acad Sci 2005, 1054:433-438. 10.1196/annals.1345.066, 16339693.
19. Ma Q, Abel K, Sripichai O, et al. Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia. Clin Genet 2007, 72:497-505.
20. Terwilliger JD. Inflated false-positive rates in Hardy-Weinberg and linkage-equilibrium tests are due to sampling on the basis of rare familial phenotypes in finite populations. Am J Hum Genet 2000, 67:258-259. 10.1086/302964, 1287089, 10848498.
21. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100:9440-9445. 10.1073/pnas.1530509100, 170937, 12883005.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
23. Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc NatlAcad Sci USA 2008, 105:11869-11874.
24. Wong YC, George E, Tan KL, Yap SF, Chan LL, Tan JA. Molecular characterisation and frequency of Ggamma Xmn I polymorphism in Chinese and Malay beta-thalassaemia patients in Malaysia. Malays JPathol 2006, 28:17-21.
25. Loots GG. Genomic identification of regulatory elements by evolutionary sequence comparison and functional analysis. Adv Genet 2008, 61:269-293. full_text, 18282510.
26. Feingold EA, Penny LA, Nienhuis AW, Forget BG. An olfactory receptor gene is located in the extended human beta-globin gene cluster and is expressed in erythroid cells. Genomics 1999, 61:15-23. 10.1006/geno.1999.5935, 10512676.
27. Fang X, Xiang P, Yin W, Stamatoyannopoulos G, Li Q. Cooperativeness of the higher chromatin structure of the beta-globin locus revealed by the deletion mutations of DNase I hypersensitive site 3 of the LCR. J Mol Biol 2007, 365:31-37. 10.1016/j.jmb.2006.09.072, 2826273, 17056066.
28. Zheng J, Shen W, He DZ, Long KB, Madison LD, Dallos P. Prestin is the motor protein of cochlear outer hair cells. Nature 2000, 405:149-155. 10.1038/35012009, 10821263.
29. Yanagi S, Shimbara N, Tamura T. Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors. Biochem Biophys Res Commun 2000, 279:568-573. 10.1006/bbrc.2000.3969, 11118327.
30. Sullivan FX, Kumar R, Kriz R, et al. Molecular cloning of human GDP-mannose 4,6-dehydratase and reconstitution of GDP-fucose biosynthesis in vitro. J Biol Chem 1998, 273:8193-8202. 10.1074/jbc.273.14.8193, 9525924.